-
Jan 7, 2025 | 
stockwatch.com | Ryan Kelly
REC-3565 is a potential best-in-class MALT1 inhibitor for multiple hematology indications, designed to reduce the risk of hyperbilirubinemia, a common side effect of other MALT1 inhibitors REC-4539, a potential best-in-class LSD1 inhibitor, is the first designed to be reversible and CNS penetrant for small-cell lung cancer Salt Lake City, UT, Jan.
-
Oct 30, 2024 | 
stockwatch.com | Ryan Kelly
2024-10-30 08:22 ET - News Release
Salt Lake City, UT, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide business updates and report its Q3 2024 financial results on Wednesday, Nov 6, 2024, following the close of the financial markets.
-
Sep 11, 2024 | 
amtonline.org | Bonnie Gurney |Ryan Kelly |Christopher Chidzik
Orders of manufacturing technology, measured by the U.S. Manufacturing Technology Orders report published by AMT, totaled $321.7 million in July 2024, showing declines of 19.3% from June 2024 and 7.8% compared to July 2023. DOWNLOAD PRESS RELEASEMcLean, Va. (September 11, 2024) — Orders of manufacturing technology, measured by the U.S. Manufacturing Technology Orders (USMTO) report published by AMT – The Association For Manufacturing Technology, totaled $321.7 million in July 2024.
-
Sep 5, 2024 | 
amtonline.org | Christopher Chidzik |Ryan Kelly |Amber Flora Thomas
On September 5, 2024, the U.S. Department of Commerce's Bureau of Industry and Security (BIS) published an interim final rule implementing export controls on critical and emerging technologies that align with the regulations of U.S. allies. On September 5, 2024, the U.S. Department of Commerce's Bureau of Industry and Security (BIS) published an interim final rule implementing export controls on critical and emerging technologies that align with the regulations of U.S. allies.
-
Aug 14, 2024 | 
amtonline.org | Christopher Chidzik |Ryan Kelly
Gain fresh ideas for a more efficient and connected supply chain that boosts profitability. Learn practical strategies from industry leaders at the IMTS 2024 Supply Chain Forum taking place on Wed., Sept. 11. Over the past few years, global supply chain disruption has caused manufacturers to seek better ways to source parts and distribute products.
-
Jul 30, 2024 | 
amtonline.org | Conchi Aranguren |Ryan Kelly |Stephen LaMarca |Bill Herman
For members only: Rest and regroup in this private space at IMTS 2024. Open daily from Sept. 9-14. We have to keep our phones, laptops, and tablets running at all times. We carry portable batteries and cords. We’ll even sit on the floor to be near an outlet. But do you know what else needs to be charged? You! IMTS 2024 is proud to host the AMT Member Lounge, the human charging station exclusively for AMT Members. Open daily from Sept.
-
Jul 10, 2024 | 
amtonline.org | Bonnie Gurney |Christopher Chidzik |Ryan Kelly
In this AMT+ Industry Chat, I sat down with Harry Moser, founder of the Reshoring Initiative and previous president of GF Machining Solutions, and Andrew Osborn, general manager of the cylindrical department at United Grinding (IMTS booth #236802), to discuss the hottest tech trends in the manufacturing supply chain.
-
Jun 26, 2024 | 
stockwatch.com | Ryan Kelly
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,230 shares of its Class A common stock at a price to the public of $6.50 per share. All of the shares are to be sold by Recursion.
-
May 24, 2024 | 
stockwatch.com | Ryan Kelly
SALT LAKE CITY, May 24, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that Robert Hershberg, M.D., Ph.D, has been appointed the new Chair of the Board of Recursion, effective at the end of this term, as Martin Chavez exits after more than four years of leadership.
-
Dec 4, 2023 | 
amtonline.org | Catherine Ross |Benjamin Moses |Michelle Edmonson |Ryan Kelly
Human brains excel at recognizing patterns, and some find it challenging to concentrate on repetitive details, leading to complexities in inspection tasks. Learn how using “robots-as-a-service” offers a solution in Season 2 of “Smart(er) Shop" on IMTS.com A custom-engineered automation cell can be complex, costly, time-consuming, plus it is designed for a specific application and challenging to redeploy.
